CME: Migraine Headaches: Therapeutic Updates and Contemporary Management Strategies

Cost: Free

View Offer chevron_right


Migraine headache is the leading condition of recurrent cephalalgias of moderate or severe intensity. The condition has been identified as one of the most common neurological disorders occurring in adult women (17%) approximately three times more than in men: in the U.S. 17.1% of women and 5.6% of men experience at least one migraine per year. It is one of the top five reasons for emergency department visits by patients ages 18 to 44.

By the end of the session the participant will be able to:

  • Describe clinical features of migraines, the rationale for understanding migraine as a syndrome, and migraine neurochemistry (including calcitonin gene-related peptide, serotonin, etc.) such that that they inform pairing with treatment mechanisms
  • Describe the characteristics of diagnosis of episodic and chronic migraines and the qualities
  • embodied by patients suitable for prophylactic pharmacotherapy, and apply that knowledge to patient cases

  • List present and emerging pharmacotherapeutic treatment options for both prophylactic and rescue therapies for migraine headaches and apply them to patient cases using evidence-based medicine
  • Describe challenges to the successful management of migraine, including through a collaborative care, team-based approach between disciplines

Target Audience:

Healthcare professionals who are: primary care physicians, neurologists, headache specialists, nurse practitioners, physician assistants, nurses, and pharmacists who specialize in neurology and primary care; and those who otherwise commonly care for or clinically encounter patients who may experience migraine headache.

Stay up-to-date

Receive special offers, keep up with MOC requirements and stay informed of the latest offerings in free online CME in your specialty.